63,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
  • Broschiertes Buch

This publication provides comprehensive multidisciplinary guidance to promote standardized, effective and safe implementation of best practices for treating neuroendocrine and gastro-entero-pancreatic tumours through applying peptide receptor radionuclide therapy (PRRNT). Taking into account the latest international classifications of neuroendocrine tumours, both PRRNT as a sole treatment and as a treatment in combination with other options are considered. Comprehensive protocols for employing either 90Y or 177Lu tagged somatostatin receptor-targeting peptides and clinically tested protocols…mehr

Produktbeschreibung
This publication provides comprehensive multidisciplinary guidance to promote standardized, effective and safe implementation of best practices for treating neuroendocrine and gastro-entero-pancreatic tumours through applying peptide receptor radionuclide therapy (PRRNT). Taking into account the latest international classifications of neuroendocrine tumours, both PRRNT as a sole treatment and as a treatment in combination with other options are considered. Comprehensive protocols for employing either 90Y or 177Lu tagged somatostatin receptor-targeting peptides and clinically tested protocols for renal protection are presented. The publication comprises a comprehensive compilation of medical evidence and experience. Furthermore, it contains clinical presentations, eligibility criteria and means of assessing the effectiveness of therapy utilizing molecular and morphological medical imaging techniques. The publication is a practical reference for specialists in clinical oncology and in nu
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.